Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Lustgarten Foundation hosts Seeing Beyond, Lustgarten's inaugural pancreatic cancer research symposium


News provided by

Lustgarten Foundation

Nov 20, 2023, 16:15 ET

Share this article

Share toX

Share this article

Share toX

From left to right: Andrew Rakeman, PhD, Elizabeth Jaffee, MD, Bert Vogelstein, MD, Andrew Lustgarten, Lustgarten Foundation Chairman, and Linda Tantawi, Lustgarten Foundation CEO
From left to right: Andrew Rakeman, PhD, Elizabeth Jaffee, MD, Bert Vogelstein, MD, Andrew Lustgarten, Lustgarten Foundation Chairman, and Linda Tantawi, Lustgarten Foundation CEO

Research pioneers, experts, and early career investigators unite LIVE in New York City for Seeing Beyond, honoring the organization's 25th anniversary year.

NEW YORK, Nov. 20, 2023 /PRNewswire-PRWeb/ -- On Wednesday, November 15, 2023, the Lustgarten Foundation hosted their inaugural pancreatic cancer research symposium, Seeing Beyond. The Foundation is the largest private funder of pancreatic cancer research in the world, funding preeminent pancreatic cancer researchers, driving the pursuit of bold and innovative science toward earlier detection and better treatments, transforming pancreatic cancer into a curable disease. Since its inception in 1998, Lustgarten has invested nearly $280 million in pancreatic cancer research.

"We are honored to have hosted the most influential scientists in pancreatic cancer research at our inaugural symposium, Seeing Beyond," said Linda Tantawi, CEO of the Lustgarten Foundation. "It was an incredibly collaborative experience that highlighted the most promising science in the field and the researchers who are leading the way to life-saving breakthroughs. We are so grateful to the American Association for Cancer Research (AACR), ClearNote Health, Exact Sciences, Merus, and The Gloria J. Rosenthal Memorial Fund for supporting our mission to transform pancreatic cancer into a curable disease by sponsoring the event."

"We are honored to have hosted the most influential scientists in pancreatic cancer research at our inaugural symposium, Seeing Beyond," said Linda Tantawi, CEO of the Lustgarten Foundation.

Post this

Seeing Beyond sessions were moderated by world-renowned pancreatic cancer experts, David Tuveson, MD, PhD, Director of the Cold Spring Harbor Laboratory Cancer Center and Lustgarten Chief Scientist, and Elizabeth Jaffee, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Lustgarten Chief Medical Advisor. Dr. Tuveson led Session I: "Redefining Early Pancreatic Cancer—Detection and Interception," which featured presentations from Brian M. Wolpin, MD, PhD, Dana-Farber Cancer Institute, Marcia (Mimi) Canto, MD, MHS, The Johns Hopkins University School of Medicine, Anne Marie Lennon, MBBCh, PhD, The Johns Hopkins University School of Medicine, and Peter J. Allen, MD, Duke University School of Medicine. Dr. Jaffee led Session II: "Clinical Research – Towards Personalized & Targeted Pancreatic Cancer Treatments," which included presentations from Jen Jen Yeh, MD, University of North Carolina at Chapel Hill, Jennifer J. Knox, MSc, MD, FRCPC, Princess Margaret Cancer Centre, and Vinod P. Balachandran, MD, Memorial Sloan Kettering Cancer Center. Seeing Beyond also showcased a poster session, highlighting the pioneering work and accomplishments of Lustgarten's unique LABS (Lustgarten Advancing Breakthrough Science) Programs.

The Lustgarten Luminary Award was presented to Bert Vogelstein, MD, Professor of Oncology, HHMI Investigator, the Ludwig Center, Johns Hopkins Medicine, for his visionary and groundbreaking contributions to pancreatic cancer research. Dr. Vogelstein gave an illuminating lecture, noting, "The future is now for pancreatic cancer research and having foundations like the Lustgarten Foundation who have the courage to fund creative research are essential." Dr. Vogelstein has led the LABS (Lustgarten Advancing Breakthrough Science) site at Johns Hopkins University in Baltimore, MD since 2019 and is one of the world's most cited scientists.

"The progress we've made over the past 25 years is encouraging but there's still much more work to be done," said Andrew Rakeman, Lustgarten Foundation VP of Research. "The only way to better understand this devastating disease is through steadfast research and the Lustgarten Foundation is leading the way."

In 1998, 51-year-old Marc Lustgarten, Cablevision Vice Chairman, was diagnosed with pancreatic cancer. Shocked by the lack of treatment options, the Lustgarten Foundation was created to advance the research related to the diagnosis, treatment, cure and prevention of pancreatic cancer while raising public awareness and providing support for patients and their families. This year, Lustgarten Foundation celebrates its 25th anniversary as the driving force in every major advancement in pancreatic cancer research. For more information, visit http://www.lustgarten.org.

Media Contact

Alexas Santiago, Lustgarten Foundation, 8455586314, [email protected], https://lustgarten.org/

SOURCE Lustgarten Foundation

Modal title

Seeing Beyond "Rising Stars" poster session
Seeing Beyond "Rising Stars" poster session
Session I: “Redefining Early Pancreatic Cancer—Detection and Interception”
Session I: “Redefining Early Pancreatic Cancer—Detection and Interception”
Seeing Beyond "Rising Stars" poster session Session I: “Redefining Early Pancreatic Cancer—Detection and Interception”

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.